HIF1A and AL amyloidosis: Previous studies have demonstrated that ROS-induced stabilization of hypoxia-inducible factor 1-alpha (HIF-1α) in the bone marrow microenvironment of multiple myeloma patients promotes the expression of proangiogenic genes and contributes to resistance to immunomodulatory drugs and proteasome inhibitors [29].